CAPR - Capricor Therapeutics GAAP EPS of -$0.29 beats by $0.06 revenue of $3.92M beats by $2.32M
2023-08-07 16:32:30 ET
- Capricor Therapeutics press release ( NASDAQ: CAPR ): Q2 GAAP EPS of -$0.29 beats by $0.06 .
- Revenue of $3.92M beats by $2.32M .
- The Company’s cash, cash equivalents and marketable securities totaled approximately $37.8 million as of June 30, 2023 compared to approximately $41.4 million on December 31, 2022.
For further details see:
Capricor Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $3.92M beats by $2.32M